Novel 2'- and 3'- Branched Carbocyclic Nucleosides will be synthesized and Evalua
Novel 2'- and 3'- Branched Carbocyclic Nucleosides will be synthesized and Evalua
批准号:
8145654
负责人:
Vishnumurthy R Hegde
金额:
$10.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-23 至 2012-08-31
关键词:
AdenineAdenosine KinaseAntiviral AgentsAppearanceBindingBinding SitesBiologicalBiological AssayBioterrorismCarbohydratesCarbonCellsCollaborationsDeaminationDevelopmentDiseaseDrug resistanceElementsEnzymesEvaluationExhibitsFutureGoalsHepatitis B VirusHepatitis C virusHerpesviridaeHomocysteineHomocystineHydrogen BondingHydrolaseIn VitroInfluenzaInfluenza A Virus, H1N1 SubtypeLeadLiteratureMalignant NeoplasmsModificationMolecular ConformationMolecular TargetNational Institute of Allergy and Infectious DiseaseNatureNucleosidesOrthopoxvirusOutcomePharmaceutical PreparationsPhosphorylationPhosphotransferasesPositioning AttributePoxviridaePropertyPurinesPyrimidineReportingResearch Project GrantsRiboseSeriesSevere Acute Respiratory SyndromeSmallpoxStructureStructure-Activity RelationshipTestingUracilVariantViralVirusVirus DiseasesWest Nile virusYellow Feveradenosine deaminaseanalogaristeromycinbasecandidate identificationclinically relevantcytosine analogcytotoxicitydesignerythroseflexibilityhydroxyl groupinhibitor/antagonistmolecular recognitionnovelnucleoside analogpublic health relevancepurineresistant strainrespiratory virussugar
中文摘要
描述(由申请人提供):新病毒性疾病(如HCV、SARS、西尼罗河病毒、H1N1流感)的出现、使用天花的生物恐怖主义威胁的增加以及对现有药物耐药的新病毒株的出现,保证了新药的开发。该提案的目标是发现新的抗病毒候选药物,通过修饰碳环核苷类似物来治疗此类疾病。合成的新类似物将接受针对多种病毒的抗病毒活性测试。
公共卫生相关性:该提案的目标是发现新的抗病毒候选药物,以治疗新的病毒性疾病,如HCV,SARS,西尼罗河病毒,H1N1流感和生物恐怖主义剂天花。拟议的研究项目还侧重于通过修饰一种碳环核苷类似物来开发对现有药物具有耐药性的病毒株的新药。
英文摘要
DESCRIPTION (provided by applicant): The emergence of new viral diseases such as HCV, SARS, West Nile virus, H1N1 influenza, increased threat of bioterrorism using smallpox and appearance of new viral strains resistant to existing drugs warrants development of new medications. The goal of this proposal is to discover new antiviral candidates to treat such diseases by modifying a lead carbocyclic nucleoside analog. New analogs synthesized will be tested for antiviral activity against a wide array of viruses.
PUBLIC HEALTH RELEVANCE: The goal of this proposal is to discover new antiviral candidates to treat new viral diseases such as HCV, SARS, West Nile virus, H1N1 influenza, and bioterrorism agent smallpox. The proposed research project also focuses on the development of new medications to viral strains resistant to existing drugs by modifying a lead carbocyclic nucleoside analog.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel 2'- and 3'- Branched Carbocyclic Nucleosides will be synthesized and Evalua
-
批准号:7871755
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2010
-
负责人:Vishnumurthy R Hegde
-
依托单位:
海外基金